About Ascend

Ascend is a cancer immunotherapy company developing medicines to treat primary, recurrent and metastatic cancers. Cancers are made up of many different cell types and a number of these can regulate the local tumour microenvironment to promote tumour growth.

Ascend's strategy focuses on targeting these key cells and to alter the local microenvironment and host response from one that endows tumour growth to one that causes cancer eradication.